1f28: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
[[Image:1f28.gif|left|200px]]
{{Seed}}
[[Image:1f28.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1f28|  PDB=1f28  |  SCENE=  }}  
{{STRUCTURE_1f28|  PDB=1f28  |  SCENE=  }}  


'''CRYSTAL STRUCTURE OF THYMIDYLATE SYNTHASE FROM PNEUMOCYSTIS CARINII BOUND TO DUMP AND BW1843U89'''
===CRYSTAL STRUCTURE OF THYMIDYLATE SYNTHASE FROM PNEUMOCYSTIS CARINII BOUND TO DUMP AND BW1843U89===




==Overview==
<!--  
BACKGROUND: Using fixed receptor sites derived from high-resolution crystal structures in structure-based drug design does not properly account for ligand-induced enzyme conformational change and imparts a bias into the discovery and design of novel ligands. We sought to facilitate the design of improved drug leads by defining residues most likely to change conformation, and then defining a minimal manifold of possible conformations of a target site for drug design based on a small number of identified flexible residues. RESULTS: The crystal structure of thymidylate synthase from an important pathogenic target Pneumocystis carinii (PcTS) bound to its substrate and the inhibitor, BW1843U89, is reported here and reveals a new conformation with respect to the structure of PcTS bound to substrate and the more conventional antifolate inhibitor, CB3717. We developed an algorithm for determining which residues provide 'soft spots' in the protein, regions where conformational adaptation suggests possible modifications for a drug lead that may yield higher affinity. Remodeling the active site of thymidylate synthase with new conformations for only three residues that were identified with this algorithm yields scores for ligands that are compatible with experimental kinetic data. CONCLUSIONS: Based on the examination of many protein/ligand complexes, we develop an algorithm (SOFTSPOTS) for identifying regions of a protein target that are more likely to accommodate plastically to regions of a drug molecule. Using these indicators we develop a second algorithm (PLASTIC) that provides a minimal manifold of possible conformations of a protein target for drug design, reducing the bias in structure-based drug design imparted by structures of enzymes co-crystallized with inhibitors.
The line below this paragraph, {{ABSTRACT_PUBMED_11358692}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 11358692 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_11358692}}


==About this Structure==
==About this Structure==
Line 29: Line 33:
[[Category: Beta-sheet]]
[[Category: Beta-sheet]]
[[Category: Protein-inhibitor complex]]
[[Category: Protein-inhibitor complex]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 15:48:02 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 1 02:21:57 2008''

Revision as of 02:22, 1 July 2008

File:1f28.png

Template:STRUCTURE 1f28

CRYSTAL STRUCTURE OF THYMIDYLATE SYNTHASE FROM PNEUMOCYSTIS CARINII BOUND TO DUMP AND BW1843U89CRYSTAL STRUCTURE OF THYMIDYLATE SYNTHASE FROM PNEUMOCYSTIS CARINII BOUND TO DUMP AND BW1843U89

Template:ABSTRACT PUBMED 11358692

About this StructureAbout this Structure

1F28 is a Single protein structure of sequence from Pneumocystis carinii. Full crystallographic information is available from OCA.

ReferenceReference

Approaches to solving the rigid receptor problem by identifying a minimal set of flexible residues during ligand docking., Anderson AC, O'Neil RH, Surti TS, Stroud RM, Chem Biol. 2001 May;8(5):445-57. PMID:11358692

Page seeded by OCA on Tue Jul 1 02:21:57 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA